Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Havlir

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Infectious Diseases|March 1, 1995
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infectionD Havlir, S H Cheeseman, M McLaughlin, et al.
The Journal of Infectious Diseases|July 1, 1994
The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDSC A Kemper, D Havlir, D Haghighat, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 30, 2026
Incidence and predictors of TB infection among children and adolescents in the SONET studyR Abbott, E Kakande, B Ssekyanzi, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1995
Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virusS H Cheeseman, D Havlir, M M McLaughlin, et al.
The Journal of Infectious Diseases|December 23, 1999
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapyT Schacker, S Little, E Connick, et al.
The Journal of Infectious Diseases|February 15, 2001
Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infectionT Schacker, S Little, E Connick, et al.
BMC Public Health|December 13, 2022
Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan AfricaK Sabapathy, L Balzer, J Larmarange, et al.
The New England Journal of Medicine|September 11, 1997
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapyR M Gulick, J W Mellors, D Havlir, et al.
Clinical Pharmacology and Therapeutics|February 11, 2017
Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria ChemopreventionR Kajubi, L Huang, P Jagannathan, et al.
Annals of Internal Medicine|July 6, 2000
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudineR M Gulick, J W Mellors, D Havlir, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|March 1, 1995
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infectionD Havlir, S H Cheeseman, M McLaughlin, et al.
The Journal of Infectious Diseases|July 1, 1994
The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDSC A Kemper, D Havlir, D Haghighat, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 30, 2026
Incidence and predictors of TB infection among children and adolescents in the SONET studyR Abbott, E Kakande, B Ssekyanzi, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1995
Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virusS H Cheeseman, D Havlir, M M McLaughlin, et al.
The Journal of Infectious Diseases|December 23, 1999
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapyT Schacker, S Little, E Connick, et al.
The Journal of Infectious Diseases|February 15, 2001
Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infectionT Schacker, S Little, E Connick, et al.
BMC Public Health|December 13, 2022
Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan AfricaK Sabapathy, L Balzer, J Larmarange, et al.
The New England Journal of Medicine|September 11, 1997
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapyR M Gulick, J W Mellors, D Havlir, et al.
Clinical Pharmacology and Therapeutics|February 11, 2017
Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria ChemopreventionR Kajubi, L Huang, P Jagannathan, et al.
Annals of Internal Medicine|July 6, 2000
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudineR M Gulick, J W Mellors, D Havlir, et al.
Pageof 4